Conivaptan Interactions
There are 434 drugs known to interact with conivaptan, along with 4 disease interactions. Of the total drug interactions, 213 are major, 199 are moderate, and 22 are minor.
- View all 434 medications that may interact with conivaptan
- View conivaptan disease interactions (4)
Most frequently checked interactions
View interaction reports for conivaptan and the medicines listed below.
- Adcetris (brentuximab)
- Adriamycin (doxorubicin)
- Advate (antihemophilic factor)
- Amytal Sodium (amobarbital)
- Bicillin L-A (penicillin g benzathine)
- Bivigam (immune globulin intravenous)
- Braftovi (encorafenib)
- Brethine (terbutaline)
- Brevibloc (esmolol)
- Brevital Sodium (methohexital)
- Byfavo (remimazolam)
- Cytoxan (cyclophosphamide)
- Diacomit (stiripentol)
- Emgality (galcanezumab)
- Entereg (alvimopan)
- Etopophos (etoposide)
- Fluothane (halothane)
- Forane (isoflurane)
- GamaSTAN S/D (immune globulin intramuscular)
- Givlaari (givosiran)
- Halfan (halofantrine)
- Heparin Sodium (heparin)
- Infuvite Pediatric (multivitamin)
- Ingrezza (valbenazine)
- Invega Trinza (paliperidone)
- Iodides (sodium iodide)
- Iron Chews (carbonyl iron)
- Iron Sulfate (ferrous sulfate)
- Juluca (dolutegravir / rilpivirine)
- Lanoxin (digoxin)
Conivaptan disease interactions
There are 4 disease interactions with conivaptan which include:
Report options
QR code containing a link to this page
More about conivaptan
- conivaptan consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: vasopressin antagonists
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
